What does CUSIP 36151G709 represent in this 13F holders report?

CUSIP 36151G709 is the security identifier for INBS - INTELLIGENT BIO SOLUTIONS INC. - COM NEW used to aggregate holder disclosures.

How many institutions held INBS - INTELLIGENT BIO SOLUTIONS INC. - COM NEW in Q1 2026?

9 institutional investors reported INBS - INTELLIGENT BIO SOLUTIONS INC. - COM NEW for Q1 2026. Use the holders table for investor-level position and value details.

INTELLIGENT BIO SOLUTIONS INC. - COM NEW (INBS)

CUSIP: 36151G709

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class: Equity / COM NEW
Total 13F shares: 208,355
Share change: +192,937
Total reported value: $696,947
Price per share: $3.34
Number of holders: 9
Value change: +$644,539
Number of buys: 4
Number of sells: 5

Quarterly Holders Quick Answers

What is CUSIP 36151G709?
CUSIP 36151G709 identifies INBS - INTELLIGENT BIO SOLUTIONS INC. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2025

Recent filing periods for CUSIP 36151G709:

Q1 2026 Q4 2025

Top shareholders of INBS - INTELLIGENT BIO SOLUTIONS INC. - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Life Science Biosensor Diagnostics Pty Ltd	3/4/5	Former 10% owner	— class O/S missing	1,081,804	$2,001,337	—	17 Feb 2022	3/4/5
Ma-Ran Foundation	3/4/5	10%+ Owner	— class O/S missing	213,265	$394,540	—	12 May 2023	3/4/5
Gary W. Rollins Foundation	3/4/5	10%+ Owner	— class O/S missing	190,489	$352,405	—	12 May 2023	3/4/5
Spiro Kevin Sakiris	3/4/5	Chief Financial Officer	— class O/S missing	35,892	$140,337	—	18 Mar 2026	3/4/5
Harry Simeonidis	3/4/5	Chief Executive Officer	— class O/S missing	34,540	$135,051	—	18 Mar 2026	3/4/5
BIGGER CAPITAL FUND L P	13D/G	Bigger Michael	5%	303,032	$50,000	$0	31 Dec 2024	13D/G
UBS Group AG	13F	Company	— class O/S missing	4,054	$38,635	—	31 Dec 2025	13F
George Margelis	3/4/5	Director	— class O/S missing	15,000	$27,750	—	10 Oct 2022	3/4/5
Lawrence B. Fisher	3/4/5	Director	— class O/S missing	15,000	$27,750	—	10 Oct 2022	3/4/5
Steven Constantine Boyages	3/4/5	Director	— class O/S missing	5,031	$19,671	—	18 Mar 2026	3/4/5
Jonathan Scott Hurd	3/4/5	Director	— class O/S missing	5,006	$19,573	—	18 Mar 2026	3/4/5
Jason Isenberg	3/4/5	Director	— class O/S missing	5,000	$19,550	—	18 Mar 2026	3/4/5
Nicola Marion Fraser	3/4/5	Director	— class O/S missing	5,000	$19,550	—	18 Mar 2026	3/4/5
Christopher Towers	3/4/5	Director	— mixed-class rows	28,060 mixed-class rows	$18,278	—	04 Oct 2023	3/4/5
Tom Parmakellis	3/4/5	Director	— class O/S missing	9,300	$17,205	—	30 Dec 2021	3/4/5
Tower Research Capital LLC (TRC)	13F	Company	— class O/S missing	1,260	$12,008	—	31 Dec 2025	13F
CURIO WEALTH, LLC	13F	Company	— class O/S missing	200	$996	—	31 Dec 2025	13F
CITIGROUP INC	13F	Company	— class O/S missing	76	$724	—	31 Dec 2025	13F
NATIONAL BANK OF CANADA /FI/	13F	Company	— class O/S missing	35	$332	—	31 Dec 2025	13F
SHP Wealth Management	13F	Company	— class O/S missing	25	$238	—	31 Dec 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	— class O/S missing	9	$86	—	31 Dec 2025	13F
Alyeska Investment Group, L.P.	13D/G	—	10%	944,310	—	$0	30 Sep 2025	13D/G
ARMISTICE CAPITAL, LLC	13D/G	—	10%	163,571	—	$0	31 Mar 2026	13D/G

Institutional Holders of INTELLIGENT BIO SOLUTIONS INC. - COM NEW (INBS) as of Q1 2026

As of 31 Mar 2026, INTELLIGENT BIO SOLUTIONS INC. - COM NEW (INBS) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 208,355 shares. The largest 9 holders included ARMISTICE CAPITAL, LLC, Alyeska Investment Group, L.P., GEODE CAPITAL MANAGEMENT, LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD FIDUCIARY TRUST CO, Tower Research Capital LLC (TRC), UBS Group AG, OSAIC HOLDINGS, INC., and CURIO WEALTH, LLC. This page lists 9 institutional shareholders reporting positions in this security for the Q1 2026 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

Q1 2026 holders

Holder diff

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2026 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.